Page 2 - Oderick Turner News Today

Long-awaited clinical trial data show psychedelic drug is effective at treating post-traumatic stress disorder in a diversity of people. Long-awaited clinical trial data show psychedelic drug is effective at treating post-traumatic stress disorder in a diversity of people.

In trials, the antipsychotic drug brexpiprazole (Rexulti) failed to provide a clinically meaningful benefit and increased the risk of death. Yet the US Food and Drug Administration (FDA) has fast tracked its approval, making Rexulti the first antipsychotic for treating agitation in elderly patients with dementia.

In trials, brexpiprazole failed to provide a clinically meaningful benefit and it increased mortality, but the FDA fast tracked its approval and the sponsor predicts $1bn in annual sales. Robert Whitaker investigates the first licensed antipsychotic for treating agitation in elderly patients with dementia For years, health officials have tried to rein in the prescribing of atypical antipsychotics to elderly patients with dementia. The practice has been entirely “off label” yet widespread. Th...

Looking back, these men reveal some of the missteps they made and the regrets they have.

Peter Gøtzsche discusses how depression pills don’t work for children and increase their risk of suicide, including fluoxetine.

Ayurdhi Dhar interviews Erick Turner about publication bias in antidepressant trials, compromised psychotherapeutic research, and a culture of journal worship.

Council officials have been warned the general public will only start believing in Longfords well documented regeneration once work begins on the county towns...

The owner of a Longford café extensively damaged by fire two months ago has told of his delight at being able to open a pop up coffee shop just yards fro...

A new study shows antidepressants outperformed placebo in only 15% of patients, almost exclusively in those with the most severe depression.

Do antidepressants really provide lasting relief? Here's what the industry desperately doesn't want you to know. STORY AT-A-GLANCE ...